Izuralimab
Izuralimab is a bispecific IgG1 antibody targeting inducible T-cell costimulator (ICOS/CD278) and PD-1[1].
Product Specifications
CAS Number
2329669-80-7
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/izuralimab.html
Purity
99.97
Solubility
H2O
Smiles
[Izuralimab]
Molecular Weight
(126.283 kDa)
References & Citations
[1]Aghanejad A, et al. A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors. Int J Biol Macromol. 2022 May 15;207:592-610.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1216485-01 0.05 mg (E-Coli)
Recombinant Salmonella schwarzengrund UPF0299 membrane protein yohJ (yohJ)
Sign In for Pricing
View Details MBS1216485-02 0.2 mg (E-Coli)
Recombinant Salmonella schwarzengrund UPF0299 membrane protein yohJ (yohJ)
Sign In for Pricing
View Details